The Heat Shock Protein 90 Inhibitor, (-)-Epigallocatechin Gallate, Has Anticancer Activity in a Novel Human Prostate Cancer Progression Model

Cancer Prevention Research - United States
doi 10.1158/1940-6207.capr-14-0224
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

Preclinical Antitumor Activity of SST0116CL1: A Novel Heat Shock Protein 90 Inhibitor

International Journal of Oncology
Cancer ResearchOncology
2014English

Antitumor Activity and Molecular Effects of the Novel Heat Shock Protein 90 Inhibitor, IPI-504, in Pancreatic Cancer

Molecular Cancer Therapeutics
Cancer ResearchOncology
2008English

Heat Shock Protein 27 Regulates Human Prostate Cancer Cell Motility and Metastatic Progression

Oncotarget
Oncology
2014English

Abrogation of Heat Shock Protein 70 Induction as a Strategy to Increase Antileukemia Activity of Heat Shock Protein 90 Inhibitor 17-Allylamino-Demethoxy Geldanamycin

Cancer Research
Cancer ResearchOncology
2005English

Potent Activity of a Novel Dimeric Heat Shock Protein 90 Inhibitor Against Head and Neck Squamous Cell Carcinoma in Vitro and in Vivo

Clinical Cancer Research
Cancer ResearchOncology
2005English

Crowding Activates Heat Shock Protein 90

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2016English

Heat Shock Protein 90 (HSP90AA1; Hsp90)

Science-Business eXchange
2009English

Novel Epigallocatechin Gallate (EGCG) Analogs Activate AMP-activated Protein Kinase Pathway and Target Cancer Stem Cells

Bioorganic and Medicinal Chemistry
Organic ChemistryMolecular MedicineMolecular BiologyBiochemistryClinical BiochemistryPharmaceutical ScienceDrug Discovery
2012English

Identification of a Heat Shock-Like Antigen in P.falciparum, Related to the Heat Shock Protein 90 Family

Nucleic Acids Research
Genetics
1988English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy